NBDS - ETF AI Analysis
Top Page
Neuberger Berman Disrupters ETF (NBDS)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Year-To-Date Performance
The ETF has delivered strong gains so far this year, showing solid recent momentum for investors.
Leading Growth Holdings
Several top positions, including major chipmakers and fast-growing healthcare names, have shown strong performance and helped drive returns.
Focused Innovation Exposure
Heavy weighting in technology and healthcare gives investors targeted exposure to disruptive, high-growth areas of the market.
Negative Factors
High Sector Concentration
More than half of the fund is in technology, which increases the risk if that sector experiences a downturn.
Short-Term Volatility
The recent weak one-month performance suggests the fund can be volatile over shorter time periods.
Limited Geographic Diversification
With almost all assets in U.S. companies, the ETF offers little exposure to international markets.
NBDS vs. SPDR S&P 500 ETF (SPY)
AUM142.90M
RegionGlobal
Expense Ratio0.40%
Beta1.52
IssuerNeuberger Berman
Inception DateApr 06, 2022
Dividend Yield0.35%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume76,666
30 Day Avg. Volume59,224
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
50.97Price Target Upside― Downside
Rating ConsensusStrong Buy
Number of Analyst Covering30
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
NBDS Summary
NBDS, the Neuberger Berman Disrupters ETF, focuses on companies that are changing how industries work, rather than following a traditional market index. It invests in innovative businesses in areas like technology, health care, and clean energy, aiming to benefit from long-term growth driven by new ideas and digital transformation. Well-known holdings include Nvidia and AMD, both leaders in advanced computer chips. Investors might consider NBDS if they want growth potential and exposure to cutting-edge trends in one fund. A key risk is that these disruptive stocks can be very volatile, so the ETF’s value can rise and fall sharply with the market.
How much will it cost me?The Neuberger Berman Disrupters ETF (NBDS) has an expense ratio of 0.55%, meaning you’ll pay $5.50 per year for every $1,000 invested. This is higher than average because it’s actively managed, focusing on innovative companies and industries that require more research and expertise to select.
What would affect this ETF?The Neuberger Berman Disrupters ETF (NBDS) could benefit from continued advancements in technology and innovation, particularly in sectors like artificial intelligence, renewable energy, and biotechnology, where its holdings like Nvidia and Snowflake are well-positioned. However, it may face challenges from rising interest rates, which can negatively impact growth-focused companies, and potential regulatory changes in the technology and financial sectors. Additionally, global economic uncertainty could affect the performance of its diverse portfolio.
NBDS Top 10 Holdings
NBDS is leaning hard into semiconductor and AI powerhouses, with Nvidia and AMD acting as the main engines of performance thanks to their rising momentum and central role in data centers and advanced computing. ASML and ARM add more chip-focused fuel, though ARM’s recent slide shows that enthusiasm can cool quickly when valuations look stretched. On the biotech side, names like Definium Therapeutics and Protagonist Therapeutics bring punchy but more volatile gains. Overall, it’s a globally focused, innovation-heavy portfolio where a handful of disruptive tech names steer the ride.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Nvidia | 6.94% | $9.56M | $4.72T | 15.56% | 76 Outperform | |
| Definium Therapeutics | 5.72% | $7.88M | $5.91B | 415.64% | 40 Neutral | |
| Advanced Micro Devices | 4.82% | $6.63M | $791.48B | 177.32% | 73 Outperform | |
| Snowflake | 4.41% | $6.08M | $103.32B | 43.05% | 54 Neutral | |
| Protagonist Therapeutics | 4.35% | $5.99M | $8.92B | 153.84% | 68 Neutral | |
| Glaukos | 4.01% | $5.52M | $9.94B | 93.50% | 61 Neutral | |
| ASML Holding | 3.99% | $5.49M | $634.58B | 136.15% | 81 Outperform | |
| Constellation Energy Corporation | 3.92% | $5.40M | $94.64B | -22.90% | 68 Neutral | |
| Monolithic Power | 3.87% | $5.32M | $64.66B | 81.52% | 75 Outperform | |
| ARM Holdings PLC ADR | 3.65% | $5.03M | $257.00B | 74.22% | 69 Neutral |
NBDS Technical Analysis
Neutral
―
Price Trends
40.32
Negative
37.12
Positive
36.13
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For NBDS, the sentiment is Neutral. The current price of undefined is equal to the 20-day moving average (MA) of 39.97, equal to the 50-day MA of 40.32, and equal to the 200-day MA of 36.13, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for NBDS.
NBDS Peer Comparison
Comparison Results
Performance Comparison
NBDS
Neuberger Berman Disrupters ETF
38.82
4.30
12.46%
ALAI
Alger AI Enablers & Adopters ETF
―
―
―
ILDR
First Trust Innovation Leaders ETF
―
―
―
TMAT
Main Thematic Innovation ETF
―
―
―
SPRX
Spear Alpha ETF
―
―
―
YNOT
Horizon Digital Frontier ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents